Cabazitaxel with abiraterone versus abiraterone alone randomized trial for extensive disease following docetaxel: The CHAARTED2 trial of the ECOG-ACRIN Cancer Research Group (EA8153). This is an ASCO ...
Development and validation of a deep learning–based cardiovascular disease risk prediction model for long-term breast cancer survivors. The effect of sodium glucose cotransporter-2 inhibitors on ...
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with no approved treatment. Resmetirom is an oral, liver-directed, thyroid hormone receptor beta–selective agonist in development for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results